167 related articles for article (PubMed ID: 1099501)
1. Combination chemotherapy in disseminated melanoma and other solid tumors in adults.
Gerner RE; Moore GE; Dickey C
Oncology; 1975; 31(1):22-30. PubMed ID: 1099501
[TBL] [Abstract][Full Text] [Related]
2. DTIC (NSC-45388) in malignant melanoma: a perspective.
Comis RL
Cancer Treat Rep; 1976 Feb; 60(2):165-76. PubMed ID: 769969
[No Abstract] [Full Text] [Related]
3. Clinical comparison of adriamycin and a combination of methyl-CCNU and imidazole carboxamide in disseminated malignant melanoma.
Ahmann DL; Bisel HF; Edmonson JH; Hahn RG; Eagan RT; O'Connell MJ; Frytak S
Clin Pharmacol Ther; 1976 Jun; 19(6):821-4. PubMed ID: 773589
[TBL] [Abstract][Full Text] [Related]
4. A comparative clinical trial evaluating the combination of adriamycin, DTIC, and vincristine, the combination of actinomycin D, cyclophosphamide, and vincristine, and a single agent, methyl-CCNU, in advanced sarcomas.
Creagan ET; Hahn RG; Ahmann DL; Edmonson JH; Bisel HF; Eagan RT
Cancer Treat Rep; 1976 Sep; 60(9):1385-7. PubMed ID: 189922
[No Abstract] [Full Text] [Related]
5. Combination chemotherapy for disseminated malignant melanoma with DTIC, vincristine, and methyl-CCNU.
Einhorn LH; Furnas B
Cancer Treat Rep; 1977 Aug; 61(5):881-3. PubMed ID: 329981
[TBL] [Abstract][Full Text] [Related]
6. DTIC (nsc-45388) and combination therapy for melanoma. I. Studies with DTIC, BCNU (NSC-409962), CCNU (NSC-79037), vincristine (NSC-67574), and hydroxyurea (NSC-32065).
Carter RD; Krementz ET; Hill GJ; Metter GE; Fletcher WS; Golomb FM; Grage TB; Minton JP; Sparks FC
Cancer Treat Rep; 1976 May; 60(5):601-9. PubMed ID: 991149
[TBL] [Abstract][Full Text] [Related]
7. Use of combination chemotherapy with CCNU, bleomycin, and vincristine in the treatment of metastatic melanoma in patients resistant to DTIC therapy.
Everall JD; Dowd PM
Cancer Treat Rep; 1979 Jan; 63(1):151-5. PubMed ID: 84710
[No Abstract] [Full Text] [Related]
8. Results with methyl-CCNU and DTIC in metastatic melanoma.
Costanza ME; Nathanson L; Schoenfeld D; Wolter J; Colsky J; Regelson W; Cunningham T; Sedransk N
Cancer; 1977 Sep; 40(3):1010-5. PubMed ID: 332319
[TBL] [Abstract][Full Text] [Related]
9. Phase I evaluation of DTIC (NSC-45388) and other studies in malignant melanoma in the Central Oncology Group.
Johnson RO; Metter G; Wilson W; Hill G; Krementz E
Cancer Treat Rep; 1976 Feb; 60(2):183-7. PubMed ID: 769971
[TBL] [Abstract][Full Text] [Related]
10. Combination chemotherapy with DTIC (NSC-45388) in advanced malignant melanoma, soft tissue sarcomas, and Hodgkin's disease.
Beretta G; Bonadonna G; Bajetta E; Tancini G; De Lena M; Azzarelli A; Veronesi U
Cancer Treat Rep; 1976 Feb; 60(2):205-11. PubMed ID: 769975
[TBL] [Abstract][Full Text] [Related]
11. Influence of therapy on the antioxidant status in patients with melanoma.
Gadjeva V; Dimov A; Georgieva N
J Clin Pharm Ther; 2008 Apr; 33(2):179-85. PubMed ID: 18315784
[TBL] [Abstract][Full Text] [Related]
12. Eastern Cooperative Oncology Group studies with DTIC (NSC-45388).
Carbone PP; Costello W
Cancer Treat Rep; 1976 Feb; 60(2):193-8. PubMed ID: 769973
[TBL] [Abstract][Full Text] [Related]
13. Comparative study of methyl-CCNU (NSC-95441) with cyclophosphamide (NSC-26271) and 5-(3,3-dimethyl-1-triazeno)imidazole-4-carboxamide (NSC-45388) with vincristine (NSC-67574) in patients with disseminated malignant melanoma.
Ahmann DL; Hahn RG; Bisel HF; Eagan RT; Edmonson JH
Cancer Chemother Rep; 1975; 59(2 Pt 1):451-3. PubMed ID: 1097102
[No Abstract] [Full Text] [Related]
14. Bacillus Calmette-Guérin immunotherapy in combination with DTIC (NSC-45388) for the treatment of malignant melanoma.
Gutterman JU; Mavligit GM; Reed R; Burgess MA; Gottlieb J; Hersh EM
Cancer Treat Rep; 1976 Feb; 60(2):177-82. PubMed ID: 769970
[TBL] [Abstract][Full Text] [Related]
15. DTIC (NSC-45388) studies in the southwest oncology group.
Costanzi JJ
Cancer Treat Rep; 1976 Feb; 60(2):189-92. PubMed ID: 769972
[TBL] [Abstract][Full Text] [Related]
16. Use of combination adriamycin (NSC-123127) and DTIC (NSC-45388) in children with advanced stage IV neuroblastoma.
Leikin S; Bernstein I; Evans A; Finklestein J; Hittle R; Klemperer M
Cancer Chemother Rep; 1975; 59(5):1015-8. PubMed ID: 1106842
[TBL] [Abstract][Full Text] [Related]
17. A clinical trial of procarbazine plus vincristine plus bis-chloroethyl-nitrosourea plus imidazole carboxamide dimethyl triazeno in metastatic malignant melanoma.
Van Dyk JJ; Falkson G
Med Pediatr Oncol; 1975; 1(2):107-11. PubMed ID: 1228411
[TBL] [Abstract][Full Text] [Related]
18. Chemotherapy of a human malignant melanoma transplanted in the nude mouse.
Povlsen CO; Jacobsen GK
Cancer Res; 1975 Oct; 35(10):2790-6. PubMed ID: 1157050
[TBL] [Abstract][Full Text] [Related]
19. Adriamycin and CCNU in the treatment of advanced breast cancer.
Muss HB; White DR; Richards F; Cooper MR; Spurr CL
Cancer Treat Rep; 1976 Nov; 60(11):1687-9. PubMed ID: 1021240
[No Abstract] [Full Text] [Related]
20. Role of DTIC (NSC-45388) in the chemotherapy of sarcomas.
Gottlieb JA; Benjamin RS; Baker LH; O'Bryan RM; Sinkovics JG; Hoogstraten B; Quagliana JM; Rivkin SE; Bodey GP; Rodriguez V; Blumenschein GR; Saiki JH; Coltman C; Burgess MA; Sullivan P; Thigpen T; Bottomley R; Balcerzak S; Moon TE
Cancer Treat Rep; 1976 Feb; 60(2):199-203. PubMed ID: 769974
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]